Worsham PL - Search Results

1

Comparison of three non-human primate aerosol models for glanders, caused by Burkholderia mallei.

Waag DM, Chance TB, Trevino SR, Rossi FD, Fetterer DP, Amemiya K, Dankmeyer JL, Ingavale SS, Tobery SA, Zeng X, Kern SJ, Worsham PL, Cote CK, Welkos SL. Waag DM, et al. Among authors: worsham pl. Microb Pathog. 2021 Jun;155:104919. doi: 10.1016/j.micpath.2021.104919. Epub 2021 Apr 27. Microb Pathog. 2021. PMID: 33915206

2

Postexposure prophylaxis against experimental inhalation anthrax.

Friedlander AM, Welkos SL, Pitt ML, Ezzell JW, Worsham PL, Rose KJ, Ivins BE, Lowe JR, Howe GB, Mikesell P, et al. Friedlander AM, et al. Among authors: worsham pl. J Infect Dis. 1993 May;167(5):1239-43. doi: 10.1093/infdis/167.5.1239. J Infect Dis. 1993. PMID: 8486963

3

Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops).

Davis KJ, Fritz DL, Pitt ML, Welkos SL, Worsham PL, Friedlander AM. Davis KJ, et al. Among authors: worsham pl. Arch Pathol Lab Med. 1996 Feb;120(2):156-63. Arch Pathol Lab Med. 1996. PMID: 8712895

4

Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis.

Welkos SL, Davis KM, Pitt LM, Worsham PL, Freidlander AM. Welkos SL, et al. Among authors: worsham pl. Contrib Microbiol Immunol. 1995;13:299-305. Contrib Microbiol Immunol. 1995. PMID: 8833858 No abstract available.

5

Construction of defined F1 negative mutants of virulent Yersinia pestis.

Worsham PL, Stein MP, Welkos SL. Worsham PL, et al. Contrib Microbiol Immunol. 1995;13:325-8. Contrib Microbiol Immunol. 1995. PMID: 8833864 No abstract available.

6

Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis.

Friedlander AM, Welkos SL, Worsham PL, Andrews GP, Heath DG, Anderson GW Jr, Pitt ML, Estep J, Davis K. Friedlander AM, et al. Among authors: worsham pl. Clin Infect Dis. 1995 Oct;21 Suppl 2:S178-81. doi: 10.1093/clinids/21.supplement_2.s178. Clin Infect Dis. 1995. PMID: 8845449 Review.

7

Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis.

Anderson GW Jr, Leary SE, Williamson ED, Titball RW, Welkos SL, Worsham PL, Friedlander AM. Anderson GW Jr, et al. Among authors: worsham pl. Infect Immun. 1996 Nov;64(11):4580-5. doi: 10.1128/iai.64.11.4580-4585.1996. Infect Immun. 1996. PMID: 8890210 Free PMC article.

8

Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis.

Anderson GW Jr, Worsham PL, Bolt CR, Andrews GP, Welkos SL, Friedlander AM, Burans JP. Anderson GW Jr, et al. Among authors: worsham pl. Am J Trop Med Hyg. 1997 Apr;56(4):471-3. doi: 10.4269/ajtmh.1997.56.471. Am J Trop Med Hyg. 1997. PMID: 9158060

9

A strategy to verify the absence of the pgm locus in Yersinia pestis strain candidates for select agent exemption.

Jenkins AL, Worsham PL, Welkos SL. Jenkins AL, et al. Among authors: worsham pl. J Microbiol Methods. 2009 Jun;77(3):316-9. doi: 10.1016/j.mimet.2009.02.013. Epub 2009 Mar 10. J Microbiol Methods. 2009. PMID: 19281840

10

CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.

Amemiya K, Meyers JL, Rogers TE, Fast RL, Bassett AD, Worsham PL, Powell BS, Norris SL, Krieg AM, Adamovicz JJ. Amemiya K, et al. Among authors: worsham pl. Vaccine. 2009 Apr 6;27(16):2220-9. doi: 10.1016/j.vaccine.2009.02.016. Epub 2009 Feb 13. Vaccine. 2009. PMID: 19428836

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page